FDX1 and cancer: CD4+T cells express programmed death 1 (PD-1) receptors, while tumor cells express the ligand to these receptors, PD-L1 [96]. Advanced cancer-infiltrating and killing abilities of NK, CD8+ T cells, and neutrophils were associated with FDX1 expression [59] .